Matthew Griffin, described as “The Adviser behind the Advisers” and a “Young Kurzweil,” is the founder and CEO of the 311 Institute, a global futures and deep futures consultancy working between the dates of 2020 to 2070, and is an award winning futurist, and author of “Codex of the Future.” Regularly featured in the global media, including AP, BBC, CNBC, Discovery, RT, and Viacom, Matthew’s ability to identify, track, and explain the impacts of hundreds of revolutionary emerging technologies on global culture, industry and society, is unparalleled. Recognised for the past six years as one of the world’s foremost futurists, innovation and strategy experts Matthew is an international speaker who helps governments, investors, multi-nationals and regulators around the world envision, build and lead an inclusive, sustainable future. A rare talent Matthew’s recent work includes mentoring Lunar XPrize teams, re-envisioning global education and training with the G20, and helping the world’s largest organisations envision and ideate the future of their products and services, industries, and countries. Matthew's clients include three Prime Ministers and several governments, including the G7, Accenture, Bain & Co, BCG, BOA, Blackrock, Bentley, Credit Suisse, Dell EMC, Dentons, Deloitte, Du Pont, E&Y, GEMS, HPE, Huawei, JPMorgan Chase, KPMG, McKinsey, PWC, Qualcomm, SAP, Samsung, Sopra Steria, UBS, and many more.
WHY THIS MATTERS IN BRIEF
There are many ways to detect disease, and one of the most effective ways is using smell, so scientists have developed a digital nose.
An electronic nose typically identifies odours by detecting the “fingerprint” of a chemical compound across an array of sensors that are monitored by pattern recognition software, and so called “E-Nose” technology is already in use across many industries, including in the agricultural, environmental, food, manufacturing, and military sectors. But now these electronic sniffers are also being tested for their ability to detect disease by sensing blood glucose levels from one’s breath and sniffing out gut disease from samples of poop. Better an electronic nose than a real one for that last one, am I right? Anyway… and it’s just one more example of how we’re democratising access to healthcare in wierd and wonderful ways, with other examples including using our common smartphones as the world’s first tricorders to detect everything from cancer and dementia, to eye disorders, inherited genetic diseases and heart disease on demand.
At Brown University in Rhode Island, electrical engineer Jacob Rosenstein and colleagues are now taking electronic noses a hop, skip, and a boogie closer to the real thing with a device that actually sniffs odours, sucking up vapours in a premeditated pattern through four pathways, and moving those vapours across chemical and mechanical sensors.
“It felt like a natural thing, to make an extension of an electronic nose that adds more contextual information,” says Rosenstein. In addition to sniffing, their device, named TruffleBot, measures small pressure and temperature changes – physical characteristics that can be used to identify a smell. For example, and here’s a fun fact for your next happy hour, beer odours cause a slight decrease in air pressure and a slight rise in temperature due to the physical properties of the alcohol vapour.
Images courtesy Brown University
In a paper the team presented recently Rosenstein’s team showed that the addition of this new information in an E-Nose raises the device’s accuracy from 80 percent to 95 percent.
E-Noses come in a variety of forms, but most rely exclusively on chemical sensors, such as metal oxides or conducting polymers. The TruffleBot goes a step further. A 3.5 inch by 2 inch circuit board that sits atop a Raspberry Pi contains eight pairs of sensors in four rows of two. Each sensor pair includes a chemical sensor to detect vapours and a mechanical sensor, in short a digital barometer, to measure air pressure and temperature.
Then comes the sniffing bit. Odour samples are pushed across these sensors by small air pumps that can be programmed to take up puffs of air in a pattern.
“When animals want to smell something, they don’t just passively expose themselves to the chemical. They’re actively sniffing for it, sampling the air and moving around, so the signals that are being received are not static,” says Rosenstein.
In an analysis of nine odours, including those from cider vinegar, lime juice, beer, wine, and vodka, and using ambient air as a control, the team found that chemical sensors alone accurately identified an odour about 80 percent of the time. The addition of sniffing improved accuracy to 90 percent. Throw in the pressure and temperature readings and the E-Nose recognised an odour 95 percent of the time.
The system is also flexible enough to swap in other types of chemical sensors, Rosenstein notes, and the overall device was relatively inexpensive at only $150 for the prototype. Next, the engineers are working to improve accuracy and response time of the device and to add new air paths and sampling systems.
“We’re definitely going to be working on improving the physical aspects of it,” says Rosenstein. The research was sponsored by DARPA, which has a history of investing in sensor technologies.
Source: Brown University